We are live on ! Find out more
CVS icon

CVS Health
CVS

1,106 hedge funds and large institutions have $59.6B invested in CVS Health in 2013 Q2 according to their latest regulatory filings, with 1,106 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

84.59% more ownership

Funds ownership: 0% → 84.59% (+85%)

14% less call options, than puts

Call options by funds: $214M | Put options by funds: $250M

Holders
1,106
Holders Change
+1,106
Holders Change %
–
% of All Funds
36.1%
Holding in Top 10
108
Holding in Top 10 Change
+108
Holding in Top 10 Change %
% of All Funds
3.52%
New
1,106
Increased
–
Reduced
–
Closed
–
Calls
$214M
Puts
$250M
Net Calls
-$35.9M
Net Calls Change
-$35.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.89B +$3.94B +68,002,343 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.19B +$3.23B +55,758,799 New
State Street
3
State Street
Massachusetts
$3.01B +$3.05B +52,717,030 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$2.72B +$2.76B +47,615,850 New
DSA
5
Davis Selected Advisers
Arizona
$2.22B +$2.25B +38,896,601 New
BIT
6
BlackRock Institutional Trust
California
$1.95B +$1.97B +34,079,553 New
Franklin Resources
7
Franklin Resources
California
$1.58B +$1.6B +27,696,771 New
Massachusetts Financial Services
8
Massachusetts Financial Services
Massachusetts
$1.43B +$1.45B +24,960,897 New
JP Morgan Chase
9
JP Morgan Chase
New York
$1.36B +$1.38B +23,830,777 New
AAM
10
Aberdeen Asset Management
United Kingdom
$1.2B +$1.22B +20,988,207 New
Northern Trust
11
Northern Trust
Illinois
$1.12B +$1.13B +19,531,956 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$1.07B +$1.08B +18,666,324 New
Capital Research Global Investors
13
Capital Research Global Investors
California
$1.03B +$1.04B +17,973,874 New
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$933M +$945M +16,317,099 New
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$640M +$649M +11,200,561 New
Norges Bank
16
Norges Bank
Norway
$629M +$637M +10,992,955 New
BFA
17
BlackRock Fund Advisors
California
$628M +$636M +10,980,454 New
BG
18
BlackRock Group
United Kingdom
$622M +$630M +10,870,929 New
Wells Fargo
19
Wells Fargo
California
$592M +$600M +10,358,989 New
Lazard Asset Management
20
Lazard Asset Management
New York
$592M +$600M +10,349,339 New
SAC
21
Smith Affiliated Capital
New York
$570M – – –
Invesco
22
Invesco
Georgia
$550M +$557M +9,619,095 New
BA
23
BlackRock Advisors
Delaware
$545M +$552M +9,526,447 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$486M +$493M +8,503,277 New
Ameriprise
25
Ameriprise
Minnesota
$469M +$475M +8,202,073 New
1
2 3 4 5

CVS Hedge Fund Activity: Q2 2013 in Review

1,106 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2013, worth a combined $59.6B.

Buyers outnumbered sellers: 1,106 funds opened new CVS positions and 0 closed out — a net gain of 1,106 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,106 institutional investors held CVS Health (CVS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $59.6B of CVS Health stock for Q2 2013.
  • 1,106 funds opened new CVS Health positions in Q2 2013 and 0 closed out, a net change of +1,106 holders.

Based on aggregated 13F filings for Q2 2013.